LEG
27
-2
IFF
56
-3
CFG
38
-2
EMN
70
-2
NVDA
52
-3
AIV
71
9
USB
44
-3
FLS
56
-3
FRT
36
-2
EIX
69
3
PG
51
3
AMP
66
-4
EOG
42
-8
INTU
63
-2
AVY
53
-9
CVS
45
-4
NWSA
47
-2
TRIP
66
5
FMC
40
4
NRG
69
12
LEG
27
-2
IFF
56
-3
CFG
38
-2
EMN
70
-2
NVDA
52
-3
AIV
71
9
USB
44
-3
FLS
56
-3
FRT
36
-2
EIX
69
3
PG
51
3
AMP
66
-4
EOG
42
-8
INTU
63
-2
AVY
53
-9
CVS
45
-4
NWSA
47
-2
TRIP
66
5
FMC
40
4
NRG
69
12
Financhill
Back

MUSQ Global Music Industry ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
26

MUSQ
MUSQ Global Music Industry ETF

Last Price:
22.25
Seasonality Move:
2.7%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
26
MUSQ Global Music Industry ETF (MUSQ) is a Sell

Is MUSQ Global Music Industry ETF a Buy, Sell or Hold?

  • The current MUSQ Global Music Industry ETF [MUSQ] share price is $22.59. The Score for MUSQ is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • MUSQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

MUSQ Stock Price Chart

What is MUSQ Global Music Industry ETF's stock price today?

  • The MUSQ Global Music Industry ETF share price today is $22.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MUSQ is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

MUSQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 45.82 Sell
Chaikin Money Flow: -411 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.35 - 23.45) Sell
Bollinger Bands (100): (23 - 24.8) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

MUSQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.51 Buy
20-day SMA: 22.78 Sell
50-day SMA: 23.31 Sell
200-day SMA: 24.38 Sell
8-day EMA: 22.56 Buy
20-day EMA: 22.72 Sell
50-day EMA: 23.18 Sell
200-day EMA: 23.95 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

MUSQ Global Music Industry ETF Earnings Growth & MUSQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

MUSQ Global Music Industry ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):